BBH vs. SURI

Last updated Jun 4, 2026

BBH (VanEck Vectors Biotech ETF) and SURI (Simplify Propel Opportunities ETF) are both Health & Biotech Equities funds. BBH is passively managed, while SURI is actively managed. Over the past 3 years, BBH returned 6.14%/yr vs 6.93%/yr for SURI. At a 0.47 correlation, their price movements are largely independent. BBH charges 0.35%/yr vs 2.51%/yr for SURI.

Performance

BBH vs. SURI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Vectors Biotech ETF (BBH) and Simplify Propel Opportunities ETF (SURI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBH achieves a -1.85% return, which is significantly lower than SURI's 6.10% return.

BBH

• 1D: 2.22%
• 1M: 0.09%
• YTD: -1.85%
• 6M: -5.32%
• 1Y: 23.92%
• 3Y*: 6.14%
• 5Y*: 0.31%
• 10Y*: 5.75%

SURI

• 1D: -1.15%
• 1M: -2.84%
• YTD: 6.10%
• 6M: 3.98%
• 1Y: 32.89%
• 3Y*: 6.93%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBH vs. SURI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
BBH VanEck Vectors Biotech ETF	-1.85%	21.18%	-4.29%	1.18%
SURI Simplify Propel Opportunities ETF	6.10%	28.32%	-13.34%	-2.87%

Correlation

The correlation between BBH and SURI is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.35
Correlation (3Y) Calculated over the trailing 3-year period	0.46
Correlation (All Time) Calculated using the full available price history since Feb 9, 2023	0.47

The correlation between BBH and SURI shifts across timeframes, from 0.35 (1 year) to 0.47 (all time), reflecting how their relationship changes across market environments.

BBH vs. SURI - Sectors Allocation Comparison

Sectors	BBH	SURI
Healthcare	99.9%	56.4%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	43.6%
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

BBH vs. SURI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBH

BBH Risk / Return Rank: 37
BBH Sharpe Ratio Rank: 35
BBH Sortino Ratio Rank: 35
BBH Omega Ratio Rank: 33
BBH Calmar Ratio Rank: 46
BBH Martin Ratio Rank: 37

SURI

SURI Risk / Return Rank: 45
SURI Sharpe Ratio Rank: 41
SURI Sortino Ratio Rank: 42
SURI Omega Ratio Rank: 39
SURI Calmar Ratio Rank: 57
SURI Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBH vs. SURI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Simplify Propel Opportunities ETF (SURI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BBH	SURI	Difference
Sharpe ratio: Return per unit of total volatility	1.26	1.46	-0.19
Sortino ratio: Return per unit of downside risk	1.89	2.11	-0.22
Omega ratio: Gain probability vs. loss probability	1.22	1.26	-0.03
Calmar ratio: Return relative to maximum drawdown	2.28	2.81	-0.53
Martin ratio: Return relative to average drawdown	5.81	7.91	-2.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBH vs. SURI - Sharpe Ratio Comparison

The current BBH Sharpe Ratio is 1.26, which is comparable to the SURI Sharpe Ratio of 1.46. The chart below compares the historical Sharpe Ratios of BBH and SURI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BBH	SURI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.26	1.46	-0.19
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.01	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.26	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.38	0.15	+0.23

Drawdowns

BBH vs. SURI - Drawdown Comparison

The maximum BBH drawdown since its inception was -72.70%, which is greater than SURI's maximum drawdown of -47.76%. Use the drawdown chart below to compare losses from any high point for BBH and SURI.

Drawdown Indicators

	BBH	SURI	Difference
Max Drawdown Largest peak-to-trough decline	-72.70%	-47.76%	-24.94%
Max Drawdown (1Y) Largest decline over 1 year	-10.55%	-11.78%	+1.23%
Max Drawdown (3Y) Largest decline over 3 years	-22.74%	-47.76%	+25.02%
Max Drawdown (5Y) Largest decline over 5 years	-39.86%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-39.86%	—	—
Current Drawdown Current decline from peak	-13.81%	-17.46%	+3.65%
Average Drawdown Average peak-to-trough decline	-20.75%	-17.37%	-3.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.13%	4.17%	-0.04%

Volatility

BBH vs. SURI - Volatility Comparison

VanEck Vectors Biotech ETF (BBH) and Simplify Propel Opportunities ETF (SURI) have volatilities of 6.06% and 5.89%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBH	SURI	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.06%	5.89%	+0.17%
Volatility (6M) Calculated over the trailing 6-month period	14.28%	14.29%	-0.01%
Volatility (1Y) Calculated over the trailing 1-year period	19.02%	22.79%	-3.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.50%	28.27%	-6.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.17%	28.27%	-6.10%

BBH vs. SURI - Expense Ratio Comparison

BBH has a 0.35% expense ratio, which is lower than SURI's 2.51% expense ratio.

Dividends

BBH vs. SURI - Dividend Comparison

BBH's dividend yield for the trailing twelve months is around 0.51%, less than SURI's 16.04% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBH VanEck Vectors Biotech ETF	0.51%	0.51%	0.80%	0.43%	0.47%	0.21%	0.36%	0.34%	0.50%	0.55%	0.30%	0.27%
SURI Simplify Propel Opportunities ETF	16.04%	16.31%	21.41%	14.71%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BBH and SURI in my portfolio?

BBH and SURI have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBH or SURI?

BBH has higher volatility (6.06%) compared to SURI (5.89%). In terms of maximum drawdown, BBH dropped -72.70% vs SURI's -47.76%.

Which ETF is better, BBH or SURI?

On 3-year performance, SURI leads with 6.93% vs 6.14% for BBH. On fees, BBH is cheaper at 0.35% per year. On volatility, SURI has been the lower-risk option at 5.89%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BBH or SURI?

Over the 3-year period, SURI has performed better with a 6.93% return vs 6.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BBH or SURI?

BBH is cheaper with a 0.35% expense ratio, compared with 2.51% for SURI.

Which ETF pays a higher dividend yield, BBH or SURI?

SURI has the higher dividend yield at 16.04%, compared with 0.51% for BBH.

What is the main difference between BBH and SURI?

They also come from different issuers: VanEck and Simplify. Their fees differ too: 0.35% for BBH and 2.51% for SURI.

Which has better risk-adjusted returns?

SURI currently has the higher Sharpe Ratio (1.46 vs 1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.